Language

News topic

ATC group B01AE07

Current shortage notices for the ATC group B01AE07, structured by product, country and reporting period.

29 notices

← All shortages

What the B01AE07 notices indicate for the supply chain

The 29 consolidated notices from Belgium, Czechia, Denmark, Austria are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Pradaxa 50 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 40 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 30 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 20 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 150 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 110 mg hard caps. 60 (60 x 1) UD

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 110 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Dabigatran Etexilate Viatris 110 mg hard caps. 60 (60 x 1) UD

Active ingredient: Dabigatran Etexilate

View notice details →
Czechia

DABIGATRAN ETEXILATE ACCORD 110MG CPS DUR 30

Active ingredient: DABIGATRAN-ETEXILÁT

View notice details →
Belgium

Dabigatran Etexilate Viatris 150 mg hard caps. 60 (60 x 1) UD

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Dabigatran Etexilate Viatris 110 mg hard caps. 180

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 150 mg hard caps. 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 110 mg hard caps. 60 (60 x 1) UD

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 50 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 40 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 30 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 20 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 150 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Belgium

Pradaxa 110 mg coat. gran. sachet 60

Active ingredient: Dabigatran Etexilate

View notice details →
Denmark

Pradaxa 50 mg overtrukket granulat

Active ingredient: Dabigatranetexilat (Dabigatranetexilatmesilat)

View notice details →
Denmark

Pradaxa 40 mg overtrukket granulat

Active ingredient: Dabigatranetexilat (Dabigatranetexilatmesilat)

View notice details →
Denmark

Pradaxa 30 mg overtrukket granulat

Active ingredient: Dabigatranetexilat (Dabigatranetexilatmesilat)

View notice details →
Denmark

Pradaxa 20 mg overtrukket granulat

Active ingredient: Dabigatranetexilat (Dabigatranetexilatmesilat)

View notice details →
Denmark

Pradaxa 150 mg overtrukket granulat

Active ingredient: Dabigatranetexilat (Dabigatranetexilatmesilat)

View notice details →
Denmark

Pradaxa 110 mg overtrukket granulat

Active ingredient: Dabigatranetexilat (Dabigatranetexilatmesilat)

View notice details →
Austria

Dabigatranetexilat Viatris 150 mg Hartkapseln

Active ingredient: DABIGATRANETEXILATMESILAT

View notice details →
Czechia

PRADAXA 150MG CPS DUR 60X1 I

Active ingredient: DABIGATRAN-ETEXILÁT

View notice details →
Austria

Dabigatranetexilat 1A Pharma 150 mg - Hartkapseln

Active ingredient: DABIGATRANETEXILATMESILAT

View notice details →
Austria

Dabigatranetexilat 1A Pharma 110 mg - Hartkapseln

Active ingredient: DABIGATRANETEXILATMESILAT

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.